Untested combinations: Novel or less-researched peptides lack even the limited safety information available for established compounds
There have been many clinical trials that show significantly improved pain and function after PRP treatment
Machiraju, P., Wang, X., Sabouny, R., Huang, J., Zhao, T., Iqbal, F., King, M., Prasher, D., Lodha, A., Jimenez-Tellez, N., Ravandi, A., Argiropoulos, B., Sinasac, D., Khan, A., Shutt, T

Long-term safety Research status : Limited long-term human studies (newer peptides) Available data : Animal studies show excellent safety Human case reports very positive No known serious adverse effects Mitochondrial support theoretically beneficial Precautionary approach : Start with lower doses Monitor how you feel Consider periodic breaks Track health markers Contraindications Avoid if : Pregnancy or breastfeeding (no safety data) Active cancer (theoretical mitochondrial support to cancer cells) Severe cardiovascular disease (consult doctor) Consult doctor if : Chronic health conditions Taking multiple medications Mitochondrial disorders (ironically, may need medical supervision) Monitoring Recommended blood work : Baseline metabolic panel Glucose/HbA1c (if using for metabolic health) Liver/kidney function Retest at 12 weeks Frequency : Every 3-6 months during long-term use Biomarkers to track : Fasting glucose Insulin sensitivity markers Inflammatory markers (hs-CRP) Energy levels (subjective) Sourcing quality NAD+ peptides Quality critical for effectiveness and safety

The few dollars you save on discount water could cost you hundreds in wasted peptides or compromised research